GW PHARMACEUTICALS PLC Revenue
GW PHARMACEUTICALS PLC reported Revenue of $6.65 million for the 3-month period ending 2018-12-31, per its 10-KT filed 2019-02-28.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2019-02-28
- GW PHARMACEUTICALS PLC revenues for the quarter ending 2018-12-31 was $6.65M, a 66.68% increase year-over-year.
- GW PHARMACEUTICALS PLC revenues for the quarter ending 2018-09-30 was $2.42M, a 1.22% decline year-over-year.
- GW PHARMACEUTICALS PLC revenues for the quarter ending 2018-06-30 was $3.28M, a 18.81% increase year-over-year.
- GW PHARMACEUTICALS PLC revenues for the quarter ending 2018-03-31 was $3.04M, a 120.20% increase year-over-year.
- GW PHARMACEUTICALS PLC revenues for fiscal 2018 was $12.74M, a 47.61% increase from fiscal 2017.
- GW PHARMACEUTICALS PLC revenues for fiscal 2017 was $8.63M, a 32.22% decline from fiscal 2016.
- GW PHARMACEUTICALS PLC revenues for fiscal 2016 was $12.73M.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2018-12-31 | $6.65M 10-KT · filed 2019-02-28 | $9.07M derived: sum of 2 quarters · filed 2019-02-28 | $12.36M derived: sum of 3 quarters · filed 2019-02-28 | $15.40M derived: sum of 4 quarters · filed 2019-02-28 |
| 2018-09-30 | $2.42M 10-KT · filed 2019-02-28 | $5.70M derived: sum of 2 quarters · filed 2019-02-28 | $8.74M derived: sum of 3 quarters · filed 2019-02-28 | $12.74M 10-K · filed 2018-11-29 |
| 2018-06-30 | $3.28M 10-KT · filed 2019-02-28 | $6.33M derived: sum of 2 quarters · filed 2019-02-28 | $10.32M derived: sum of 3 quarters · filed 2019-02-28 | $12.77M derived: sum of 4 quarters · filed 2019-02-28 |
| 2018-03-31 | $3.04M 10-KT · filed 2019-02-28 | $7.03M derived: sum of 2 quarters · filed 2019-02-28 | $9.48M derived: sum of 3 quarters · filed 2019-02-28 | $12.25M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-12-31 | $3.99M 10-KT · filed 2019-02-28 | $6.44M derived: sum of 2 quarters · filed 2019-02-28 | $9.21M derived: sum of 3 quarters · filed 2019-02-28 | $10.59M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-09-30 | $2.45M 10-KT · filed 2019-02-28 | $5.21M derived: sum of 2 quarters · filed 2019-02-28 | $6.59M derived: sum of 3 quarters · filed 2019-02-28 | $8.63M 10-K · filed 2018-11-29 |
| 2017-06-30 | $2.76M 10-KT · filed 2019-02-28 | $4.14M derived: sum of 2 quarters · filed 2019-02-28 | $6.18M derived: sum of 3 quarters · filed 2019-02-28 | |
| 2017-03-31 | $1.38M 10-KT · filed 2019-02-28 | $3.42M derived: sum of 2 quarters · filed 2019-02-28 | ||
| 2016-12-31 | $2.03M 10-KT · filed 2019-02-28 | |||
| 2016-09-30 | $12.73M 10-K · filed 2018-11-29 |